AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL
· Real-Time Price · USD
4.58
0.08 (1.78%)
At close: Aug 15, 2025, 3:59 PM
4.61
0.66%
After-hours: Aug 15, 2025, 07:54 PM EDT
AbCellera Biologics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -167.87M | -162.86M | -175.8M | -153.3M | -146.9M | -146.4M | -129.14M | -73.91M | -50.16M | 158.52M | 248.36M | 200.35M | 204.82M | 153.46M | 210.52M | 229.21M | 238.23M |
Depreciation & Amortization | 90.75M | 92.19M | 87.39M | 61.32M | 30.54M | 30.89M | 37.15M | 36.46M | 35.25M | 33.1M | 22.61M | 20.08M | 18.26M | 17.25M | 14.99M | 11.73M | 8.59M |
Stock-Based Compensation | 64.96M | 67.58M | 68.8M | 67.5M | 66.12M | 64.18M | 61.06M | 56.95M | 52.66M | 49.48M | 45.2M | 41.15M | 37.51M | 30.65M | 26.23M | 20.45M | 12.59M |
Other Working Capital | -12.67M | -16.19M | -11.72M | 34.87M | 51.86M | 30.34M | -41.92M | -223.88M | 18.25M | -33.73M | 6.02M | 194.71M | -44.45M | 36.74M | 23.28M | 3.79M | -19.01M |
Other Non-Cash Items | 23.74M | 79.84M | 96.27M | 116.95M | 51.99M | -7.74M | -3.23M | 2.3M | 3.39M | 6.43M | 5.99M | 3.69M | 3.17M | 3.57M | 1.28M | 656K | 667K |
Deferred Income Tax | n/a | n/a | 1.96M | 1.96M | 1.96M | 1.96M | n/a | n/a | n/a | n/a | 1.25M | -2.77M | -2.64M | -2.02M | 2.71M | 6.73M | 6.6M |
Change in Working Capital | 1.66M | -25.32M | -39.18M | -26.2M | 9.16M | 13.22M | 40.81M | -141.84M | 91.94M | 29.82M | -93.66M | 88.09M | -25.85M | 41.67M | 6.85M | -4.07M | -133.68M |
Operating Cash Flow | -77.89M | -108.05M | -119.66M | -90.88M | -41.52M | -43.88M | 6.65M | -120.03M | 133.08M | 277.36M | 229.74M | 350.59M | 235.26M | 244.58M | 262.57M | 264.7M | 133M |
Capital Expenditures | -64.58M | -78.08M | -76.88M | -79.26M | -86.66M | -77.51M | -75.41M | -69.03M | -73.15M | -72.66M | -69.76M | -63.82M | -69.3M | -58.45M | -50.52M | -45.84M | -12.73M |
Cash Acquisitions | 5.91M | n/a | -3.48M | -17.84M | -15.13M | -13.69M | -16.12M | -16.66M | -21.81M | -25.68M | -22.99M | -36.96M | -37.92M | -41.78M | -126.2M | -108.15M | -99.84M |
Purchase of Investments | -670.41M | -765.09M | -896.98M | -934.25M | -930.34M | -1.07B | -874.98M | -1.2B | -1.11B | -781.35M | -717.2M | -433.17M | -364.39M | -313.15M | -283.75M | -25.94M | -12.2M |
Sales Maturities Of Investments | 622.01M | 928.56M | 1.01B | 1.03B | 954.84M | 910.94M | 735.31M | 787.64M | 715.98M | 510.63M | 436.32M | 173.42M | 84.9M | 27.61M | 9.53M | n/a | n/a |
Other Investing Acitivies | 186.93M | 10.53M | 14.26M | 37.23M | 29.79M | 25.31M | 17.36M | 16.03M | 16.53M | 16.43M | 36.91M | 36.2M | 30.18M | 15.39M | -114.1M | -119.39M | -117.3M |
Investing Cash Flow | 99.43M | 121.41M | 61.38M | 44.32M | -41.59M | -221.11M | -213.85M | -483.06M | -475.86M | -352.63M | -336.71M | -324.34M | -342.78M | -332.25M | -439.28M | -173.54M | -130.04M |
Debt Repayment | 2.34M | 2.34M | 6.29M | 13.29M | 11.1M | 11.1M | 9.9M | 3.13M | 3.22M | 5.16M | 2.41M | 2.17M | -716K | -4.2M | 82.79M | 67.8M | 69.86M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.75M | -2.75M | -2.75M | -2.75M | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 14.42M | 11.28M | 5.61M | 2.09M | 2.54M | -1.23M | -3.46M | -3.33M | -2.67M | -6.79M | -2.55M | -1.4M | -4.76M | 314K | 521.43M | 521.15M | 524.5M |
Financial Cash Flow | 15.87M | 12.73M | 12.35M | 15.84M | 13.64M | 10.36M | 6.94M | 291K | 1.04M | -1.63M | -143K | 774K | -5.47M | -3.89M | 604.22M | 588.95M | 594.37M |
Net Cash Flow | 37.98M | 23.7M | -45.09M | -33.03M | -71.05M | -254.04M | -200.38M | -610.4M | -351.35M | -86.49M | -117.61M | 24.87M | -114.14M | -92.97M | 426.61M | 679.43M | 596.85M |
Free Cash Flow | -142.47M | -186.13M | -196.54M | -170.14M | -128.19M | -121.38M | -68.76M | -189.06M | 59.93M | 204.7M | 159.98M | 286.77M | 165.96M | 186.13M | 212.05M | 218.87M | 120.27M |